Ventilator Strategies in ICU Patients With COVID-19 - a National-wide Retrospective Observational Study.

NCT05102630 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1193

Last updated 2021-11-11

No results posted yet for this study

Summary

Mechanical ventilation is likely lifesaving in patients with coronavirus disease 2019 (COVID-19) but may also result in adverse events. Only few studies describe the strategies used and adverse effect of mechanical ventilation in an unselected population of ICU patients with COVID-19.

This study is designed to be a retrospective study focusing on all mechanical ventilated ICU patients with COVID-19 included in the national Danish COVID ICU database between 10.03.2020 - 02.04.2021 i.e. a total of 1,193 patients. The investigators will register the use of the core interventions around mechanical ventilation and its potential adverse event, including barotrauma and prolonged ventilation.

This study will provide important data on the ventilation strategies used and its potential adverse events in unselected ICU patients with COVID-19 and thereby inform clinicians, patients, policy-makers, and future research in this area.

Conditions

  • ARDS Due to COVID-19

Sponsors & Collaborators

  • Odense University Hospital

    collaborator OTHER
  • Aalborg University Hospital

    collaborator OTHER
  • Bispebjerg Hospital

    collaborator OTHER
  • Herlev and Gentofte Hospital

    collaborator OTHER
  • Hvidovre University Hospital

    collaborator OTHER
  • Rigshospitalet, Denmark

    collaborator OTHER
  • Aarhus University Hospital

    collaborator OTHER
  • Region Zealand

    collaborator OTHER
  • University of Southern Denmark

    lead OTHER

Principal Investigators

  • Anne C Brøchner, MD, PhD · University of Southern Denmark

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2022-02-28
Completion
2022-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05102630 on ClinicalTrials.gov